Natixis Advisors, L.P. Organon & Co. Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Organon & Co. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 48,215 shares of OGN stock, worth $717,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,215

Previous 44,695 7.88%

Holding current value

$717,921

Previous $925,000 0.32%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$18.65 - $23.03 $65,648 - $81,065	3,520 Added 7.88%	48,215 $922,000
Q2 2024 Aug 01, 2024	BUY	$17.45 - $21.96 $14,815 - $18,644	849 Added 1.94%	44,695 $925,000
Q1 2024 Apr 25, 2024	BUY	$13.78 - $18.8 $225,316 - $307,398	16,351 Added 59.47%	43,846 $824,000
Q4 2023 Feb 06, 2024	SELL	$10.95 - $17.32 $14,070 - $22,256	-1,285 Reduced 4.46%	27,495 $396,000
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $420,058 - $601,856	-25,320 Reduced 46.8%	28,780 $499,000
Q2 2023 Aug 15, 2023	BUY	$19.27 - $24.63 $576,654 - $737,052	29,925 Added 123.78%	54,100 $1.13 Million
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $450,184 - $674,225	-21,017 Reduced 46.51%	24,175 $568,000
Q4 2022 Jan 27, 2023	BUY	$23.31 - $28.61 $170,419 - $209,167	7,311 Added 19.3%	45,192 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $294,746 - $431,413	-12,596 Reduced 24.95%	37,881 $886,000
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $1,551 - $1,906	49 Added 0.1%	50,477 $1.7 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $528,916 - $683,683	17,370 Added 52.54%	50,428 $1.76 Million
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $741,520 - $960,330	-25,864 Reduced 43.9%	33,058 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $749,562 - $933,090	26,181 Added 79.96%	58,922 $1.93 Million
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $931,481 - $1.24 Million	32,741 New	32,741 $990,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Organon & Co. Transaction History